Tirzepatide (Zepbound, Mounjaro) is a dual-agonist GLP-1 medication. It works like a GLP-1 agonist, but also targets a ...

The landscape of diabetes management is undergoing a remarkable transformation. Groundbreaking research has uncovered surprising cardiovascular benefits tied to modern medications, offering new hope ...

Novo Nordisk is slashing the list prices of its flagship weight-loss and diabetes drugs, including Wegovy and Ozempic, by up ...

Individuals living with type 2 diabetes (T2D) had a significantly lower risk of poor cardiovascular health when they used a GLP-1 receptor agonist (GLP-1 RA) in combination with adhering to healthy ...

The provincial and federal governments signed a four-year agreement last year to implement a national PharmaCare initiative ...

Drugs already taken by millions of diabetes patients appear to also help slash asthma attacks by up to 70%, new research shows. Photo by Adobe Stock/HealthDay News Drugs already taken by millions of ...

This article was reviewed by Darragh O’Carroll, MD. Key takeaways: Some medications FDA-approved for type 2 diabetes can promote weight loss. Diabetes medications for weight loss include Ozmepic®, ...

Weight loss medications Mounjaro and Zepbound, which contain the active ingredient tirzepatide, may lower the risk of ...

The search for effective dementia prevention continues to challenge medical researchers worldwide. Now, a major study published in JAMA Neurology reveals that certain medications used to treat type 2 ...

Lifestyle Changes for Diabetes: Diabetes affects a large population worldwide. India also has a significant number of patients. Let us explain whether it is possible to stop taking medication. Do I ...